Moderna (MRNA) Total Current Liabilities (2017 - 2026)
Moderna (MRNA) posted quarterly Total Current Liabilities of $2.5 billion for Q2 2026, up 61.2% year-over-year from $1.6 billion in Q2 2025, and up 5.8% on a QoQ basis from $2.4 billion in Q1 2026.
Moderna (MRNA) Total Current Liabilities (2017 - 2026) Analysis & Trends
Moderna has reported Total Current Liabilities for 10 years, with the latest figure at $2.5 billion in Q2 2026.
- Total Current Liabilities for Q2 2026 came in at $2.5 billion, up 61.2% year-over-year; the trailing twelve-month figure through Jun 2026 was $2.5 billion (up 61.2% YoY), and the FY2025 annual result was $2.0 billion, down 9.93% from the prior year.
- Total Current Liabilities advanced to $2.5 billion in Q2 2026, from $2.4 billion in the prior quarter.
- Over five years, Total Current Liabilities peaked at $9.2 billion in Q1 2022 and troughed at $1.6 billion in Q2 2025.
- A 5-year average of $3.5 billion and a median of $2.5 billion in 2026 frame the typical range for Total Current Liabilities.
- The widest annual swing landed in 2023, when Total Current Liabilities sank 62.12%; it then soared 61.2% in 2026.
- A 5-year view of Total Current Liabilities shows it stood at $4.9 billion in 2022, then tumbled by 38.76% to $3.0 billion in 2023, then retreated by 26.83% to $2.2 billion in 2024, then retreated by 9.93% to $2.0 billion in 2025, then gained by 27.53% to $2.5 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $2.5 billion in Q2 2026, $2.4 billion in Q1 2026, and $2.0 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.58 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 354.06 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 2.12 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4.22 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 630.93 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.51 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 438.74 Mn |
| 10 | Moderna | 25.26 Bn | 20.13 Bn | 52.00 Mn | 2.53 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.53 Bn |
| Mar 31, 2026 | 2.40 Bn |
| Dec 31, 2025 | 1.99 Bn |
| Sep 30, 2025 | 1.68 Bn |
| Jun 30, 2025 | 1.57 Bn |
| Mar 31, 2025 | 1.60 Bn |
| Dec 31, 2024 | 2.21 Bn |
| Sep 30, 2024 | 2.20 Bn |
| Jun 30, 2024 | 2.36 Bn |
| Mar 31, 2024 | 2.38 Bn |
| Dec 31, 2023 | 3.02 Bn |
| Sep 30, 2023 | 4.39 Bn |
| Jun 30, 2023 | 3.12 Bn |
| Mar 31, 2023 | 3.50 Bn |
| Dec 31, 2022 | 4.92 Bn |
| Sep 30, 2022 | 6.81 Bn |
| Jun 30, 2022 | 6.81 Bn |
| Mar 31, 2022 | 9.24 Bn |
| Dec 31, 2021 | 9.13 Bn |
| Sep 30, 2021 | 9.96 Bn |